Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation

por Patel, Manesh R., Peacock, W. Frank, Tamayo, Sally, Sicignano, Nicholas, Hopf, Kathleen P., Yuan, Zhong
Publicado 2018

Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban

por Tamayo, Sally, Frank Peacock, W., Patel, Manesh, Sicignano, Nicholas, Hopf, Kathleen P., Fields, Larry E., Sarich, Troy, Wu, Shujian, Yannicelli, Daniel, Yuan, Zhong
Publicado 2015

Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics

por Tave, Arlene, Goehring, Earl, Desai, Vibha, Wu, Chuntao, Bohn, Rhonda L., Tamayo, Sally G., Sicignano, Nicholas, Juhaeri, Juhaeri, Jones, Judith K., Weiss, Sheila R.
Publicado 2021